Literature DB >> 10638876

Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I.

H M Oerlemans1, R A Oostendorp, T de Boo, L van der Laan, J L Severens, J A Goris.   

Abstract

OBJECTIVE: To investigate the effectiveness and cost of physical therapy (PT) or occupational therapy (OT) in patients with reflex sympathetic dystrophy (RSD).
DESIGN: Prospective randomized controlled trial, with 1 year follow-up.
SETTING: Two university hospitals. PATIENTS: One hundred thirty-five patients who had been suffering from RSD of one upper extremity for less than 1 year.
INTERVENTIONS: Patients were assigned to PT, OT, or a control group (social work). MAIN OUTCOME MEASURES: Improvement in impairment level sumscore (ISS) over 1 year (Student's t test). A difference of 5 ISS points between the groups was defined as being clinically relevant. Furthermore, severity of disability and handicap was measured and tested exploratively (Wilcoxon; alpha = .05), and cost-effectiveness of the groups was calculated.
RESULTS: PT and, to a lesser extent, OT resulted in a significant and also more rapid improvement in the ISS as compared with controls (6 and 4 ISS points, respectively). On a disability level, a positive trend was found in favor of OT. On a handicap level, no differences were found between the groups. PT had an advantage over OT regarding the cost-effectiveness ratio.
CONCLUSION: In different ways PT and OT each contribute to the recovery from RSD of the upper extremity.

Entities:  

Mesh:

Year:  2000        PMID: 10638876

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  23 in total

Review 1.  Complex [corrected] regional pain syndrome: what specialized rehabilitation services do patients require?

Authors:  I Elias Veizi; Thomas C Chelimsky; Jeffrey W Janata
Journal:  Curr Pain Headache Rep       Date:  2012-04

2.  Reflex sympathetic dystrophy: a retrospective epidemiological study of 168 patients.

Authors:  Iltekin Duman; Umit Dincer; Mehmet Ali Taskaynatan; Engin Cakar; Ilknur Tugcu; Kemal Dincer
Journal:  Clin Rheumatol       Date:  2007-01-13       Impact factor: 2.980

Review 3.  Complex Regional Pain Syndrome, Current Concepts and Treatment Options.

Authors:  Ivan Urits; Abra H Shen; Mark R Jones; Omar Viswanath; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

4.  Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.

Authors:  Tian-Zhi Guo; Tzuping Wei; Wen-Wu Li; Xiang-Qi Li; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-07-22       Impact factor: 5.820

Review 5.  Mechanism-based treatment in complex regional pain syndromes.

Authors:  Janne Gierthmühlen; Andreas Binder; Ralf Baron
Journal:  Nat Rev Neurol       Date:  2014-08-19       Impact factor: 42.937

6.  Treatment of complex regional pain syndrome type I of the hand with a series of intravenous regional sympathetic blocks with guanethidine and lidocaine.

Authors:  Kosmas I Paraskevas; Alexandra A Michaloglou; Despina D Briana; Maria Samara
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

7.  Complex regional pain syndrome type 1 in a pediatric patient: Case report.

Authors:  Ümit Seçil Demirdal; Ayşegül Bükülmez; Özlem Solak
Journal:  Turk Pediatri Ars       Date:  2014-03-01

8.  Evidence based guidelines for complex regional pain syndrome type 1.

Authors:  Roberto S Perez; Paul E Zollinger; Pieter U Dijkstra; Ilona L Thomassen-Hilgersom; Wouter W Zuurmond; Kitty Cj Rosenbrand; Jan H Geertzen
Journal:  BMC Neurol       Date:  2010-03-31       Impact factor: 2.474

9.  Complex regional pain syndrome.

Authors:  Emily S Carr; Ashley De La Cerda; Katherine Fiala
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

10.  Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophy.

Authors:  Hiske E M van Dieten; Roberto S G M Perez; Maurits W van Tulder; Jaap J de Lange; Wouter W A Zuurmond; Herman J Ader; Hindrik Vondeling; Maarten Boers
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.